Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia. The company provides its services through a network of 53 sites under the Lake Imaging, South Coast Radiology, and Global Diagnostics brands in Victoria, Queensland, and Western Australia, as well as through specialist Radiology Group, and Trinity MRI and Cavendish Radiology in Auckland, New Zealand. Integral Diagnostics Limited is headquartered in North Melbourne, Australia.
Industry, Sector and Symbol
Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone61 3 5339 0704
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$232.39 million
Profitability
Miscellaneous
Employees928
Next Earnings Date2/21/2020 (Estimated)
OptionableNot Optionable
Integral Diagnostics (ASX:IDX) Frequently Asked Questions
What is Integral Diagnostics' stock symbol?
Integral Diagnostics trades on the ASX under the ticker symbol "IDX."
How often does Integral Diagnostics pay dividends? What is the dividend yield for Integral Diagnostics?
Integral Diagnostics announced a Interim dividend on Saturday, February 23rd. Stockholders of record on Tuesday, April 2nd will be given a dividend of 0.05 per share on Tuesday, April 2nd. This represents a dividend yield of 1.85%. The ex-dividend date is Friday, March 1st. View Integral Diagnostics' Dividend History.
When is Integral Diagnostics' next earnings date?
Has Integral Diagnostics been receiving favorable news coverage?
Media stories about IDX stock have trended negative this week, according to InfoTrie Sentiment. InfoTrie scores the sentiment of press coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Integral Diagnostics earned a media sentiment score of -2.0 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 2.0 out of 10, meaning that recent press coverage is very unlikely to have an effect on the company's share price in the next several days. View News Stories for Integral Diagnostics.
Who are some of Integral Diagnostics' key competitors?
Some companies that are related to Integral Diagnostics include Volpara Health Tech (VHT), Profound Medical (PRN), Akumin (AKU), Exagen (XGN), Senseonics (SENS), Renalytix Ai (RENX), Palatin Technologies (PTN), Oncosil Medical (OSL), Yourgene Health (YGEN), MaxCyte (MXCT), Lexagene (LXG), BARD1 Life Sciences (BD1), Oncimmune (ONC), Sernova (SVA) and GeneNews (GEN).
Who are Integral Diagnostics' key executives?
Integral Diagnostics' management team includes the folowing people:
- Dr. Ian Kadish, CEO, MD & Director (Age 56)
- Ms. Anne Lockwood, Chief Financial Officer
- Dr. Chien Ping Ho, Exec. Director
- Dr. Sally Sojan, Exec. Director
- Mrs. Kathryn Davies BBus, GAICD, CPA, Company Sec.
What is Integral Diagnostics' stock price today?
One share of IDX stock can currently be purchased for approximately A$3.95.
How big of a company is Integral Diagnostics?
What is Integral Diagnostics' official website?
How can I contact Integral Diagnostics?
The company can be reached via phone at 61 3 5339 0704.
MarketBeat Community Rating for Integral Diagnostics (ASX IDX)
MarketBeat's community ratings are surveys of what our community members think about Integral Diagnostics and other stocks. Vote "Outperform" if you believe IDX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IDX will underperform the S&P 500 over the long term. You may vote once every thirty days.
